Invasive pulmonary aspergillosis and hyperthermia in an immunocompetent patient with COVID-19

Abstract

Severely ill influenza patients are at increased risk of invasive pulmonary aspergillosis (IPA). Previous reports suggest that Coronavirus Disease 2019 (COVID-19) patients may also be at increased risk of IPA. Here we present an Aspergillus co-infection in a COVID-19 immunocompetent patient, complicated by bacteremia and persistent hyperthermia. We describe the challenges in diagnosing IPA in COVID-19 immunocompetent patients and how the patient responded to the treatment.

Keywords

• COVID-19
• Invasive pulmonary aspergillosis
• Aspergillus
• Bacteremia
• Hyperthermia